|
Re: Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
11
|
Resverlogix Corp.
|
Mar 31, 2020 12:32PM
|
|
Re: Resverlogix Announces Participation at the ACC/WCC Virtual Meeting
|
4
|
Resverlogix Corp.
|
Mar 31, 2020 12:43PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 09:13AM
|
|
Re: Resverlogix Announces Participation at Premier Kidney, Alzheimer’s Disease and Cardiovascular Conferences
|
4
|
Resverlogix Corp.
|
Oct 26, 2018 01:36PM
|
|
Re: Resverlogix Announces Participation at Premier Kidney, Alzheimer’s Disease and Cardiovascular Conferences
|
6
|
Resverlogix Corp.
|
Oct 22, 2018 10:28AM
|
|
Re: Resverlogix Announces Participation at Premier Kidney, Alzheimer’s Disease and Cardiovascular Conferences
|
2
|
Resverlogix Corp.
|
Oct 28, 2018 08:33AM
|
|
Re: Resverlogix Announces Participation at Leading, International Scientific Conferences
|
1
|
Resverlogix Corp.
|
Jun 10, 2019 11:04AM
|
|
Re: Resverlogix Announces Overnight Marketed Equity Offering
|
1
|
Resverlogix Corp.
|
Jun 08, 2017 04:53PM
|
|
Re: Resverlogix Announces Overnight Marketed Equity Offering
|
1
|
Resverlogix Corp.
|
Jun 08, 2017 07:31PM
|
|
Re: Resverlogix Announces Loan Reduction and Extension
|
9
|
Resverlogix Corp.
|
Aug 02, 2019 12:20PM
|
|
Re: Resverlogix Announces Loan Reduction and Extension
|
8
|
Resverlogix Corp.
|
Aug 02, 2019 02:48PM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
3
|
Resverlogix Corp.
|
Jun 06, 2017 10:08AM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
1
|
Resverlogix Corp.
|
Jun 06, 2017 10:30AM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
1
|
Resverlogix Corp.
|
Jun 06, 2017 11:20AM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
2
|
Resverlogix Corp.
|
Jun 05, 2017 08:58AM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
5
|
Resverlogix Corp.
|
Jun 06, 2017 12:53PM
|
|
Re: Resverlogix Announces Key BETonMACE Renal Data from Plenary Session Presentation at ERA-EDTA Virtual Congress
|
2
|
Resverlogix Corp.
|
Jun 09, 2020 09:27AM
|
|
Re: Resverlogix Announces Filing of Quarterly Financial Statements and Management's Discussion & Analysis
|
5
|
Resverlogix Corp.
|
Sep 14, 2017 10:45AM
|
|
Re: Resverlogix Announces Filing of Quarterly Financial Statements and Management's Discussion & Analysis
|
4
|
Resverlogix Corp.
|
Sep 14, 2017 12:12PM
|
|
Re: Resverlogix Announces Filing of Quarterly Financial Statements and Management's Discussion & Analysis
|
5
|
Resverlogix Corp.
|
Sep 13, 2017 10:25PM
|
